APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

Conditions:   Esophageal Cancer;   GastroEsophageal Cancer
Interventions:   Drug: APX005M;   Radiation: Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Procedure: Surgical resection of tumor
Sponsors:   University of California, San Francisco;   Apexigen, Inc.
Not yet recruiting - verified May 2017

http://ift.tt/2rVsNs2